诊断学理论与实践 ›› 2023, Vol. 22 ›› Issue (03): 238-246.doi: 10.16150/j.1671-2870.2023.03.06
收稿日期:
2023-05-08
出版日期:
2023-06-25
发布日期:
2023-11-17
通讯作者:
张莉莉 E-mail:基金资助:
TANG Chunhua, GUO Lu, LI Qiong, ZHANG Lili()
Received:
2023-05-08
Online:
2023-06-25
Published:
2023-11-17
摘要:
2022年,世界卒中组织在旗下《国际卒中杂志》上发表了2项最新全球卒中统计报告,更新了全球的卒中发病率和死亡率分布,分析了性别和地理差异,并提供了卒中归因危险因素最新数据。2019年全球疾病负担研究调查结果显示,卒中仍然是世界上第二大死亡原因,也是第三大残疾合并死亡原因,从1990年至2019年,卒中的疾病负担(按绝对病例数计算)大幅增加,目前全球卒中负担以较大比例分布于低收入和中低收入国家,且70岁以下人群卒中患病率和发病率显著增加。全球卒中的五大主要危险因素包括高收缩压、高体重指数、高空腹血糖、大气颗粒物污染和吸烟。中国卒中防治正面临巨大挑战,卒中已成为中国成人致死、致残的第一位病因,也是中国伤残调整生命年的首位原因。中国卒中的发病率、患病率和死亡率在地理上存在“北高南低、中部突出”趋势;农村地区患病率高于城市;男性的发病率和死亡率均高于女性;平均发病年龄低于发达国家;缺血性卒中的疾病负担整体呈上升趋势,但出血性卒中则趋于下降;卒中防治知晓率低。综上,积极建立符合我国国情的卒中分级防控体系,具有重要战略意义。
中图分类号:
唐春花, 郭露, 李琼, 张莉莉. 2022年全球卒中数据报告解读[J]. 诊断学理论与实践, 2023, 22(03): 238-246.
TANG Chunhua, GUO Lu, LI Qiong, ZHANG Lili. Interpretation on the report of global stroke data 2022[J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 238-246.
[1] |
FEIGIN V L, BRAININ M, NORRVING B, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022[J]. Int J Stroke, 2022, 17(1):18-29.
doi: 10.1177/17474930211065917 pmid: 34986727 |
[2] |
THAYABARANATHAN T, KIM J, CADILHAC D A, et al. Global stroke statistics 2022[J]. Int J Stroke, 2022, 17(9):946-956.
doi: 10.1177/17474930221123175 URL |
[3] | 王拥军, 李子孝, 谷鸿秋, 等. 中国卒中报告2020(中文版)(1)[J]. 中国卒中杂志, 2022, 17(5):433-447. |
WANG Y J, LI Z X, GU H Q, et al. China Stroke Statistics 2020 (1)[J]. Chin J Stroke, 2022, 17(5):433-447. | |
[4] | 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4):20-36,40. |
The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary[J]. Prev Treat Cardio-Cereb-Vasc Dis, 2022, 22(4):20-36,40. | |
[5] |
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol, 2021, 20(10):795-820.
doi: 10.1016/S1474-4422(21)00252-0 pmid: 34487721 |
[6] |
OWOLABI M O, THRIFT A G, MAHAL A, et al. Primary stroke prevention worldwide: translating evidence into action[J]. Lancet Public Health, 2022, 7(1):e74-e85.
doi: 10.1016/S2468-2667(21)00230-9 URL |
[7] |
MA Q, LI R, WANG L, et al. Temporal trend and attribu-table risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12):e897-e906.
doi: 10.1016/S2468-2667(21)00228-0 URL |
[8] | LIU Z, LI Y H, CUI Z Y, et al. Prevalence of tobacco dependence and associated factors in China: Findings from nationwide China Health Literacy Survey during 2018-19[J]. Lancet Reg Health West Pac, 2022, 24:100464. |
[9] |
GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 393(10184):1958-1972.
doi: S0140-6736(19)30041-8 pmid: 30954305 |
[10] |
HE J, OGDEN L G, VUPPUTURI S, et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults[J]. JAMA, 1999, 282(21):2027-2034.
doi: 10.1001/jama.282.21.2027 URL |
[11] | 《中国居民膳食指南科学研究报告(2021)》简介[J]. 营养学报, 2021, 43(1):1-2. |
Reprort of Scientific Research on Chinese Dietary Guidelines (2021)[J]. Acta Nutrimenta Sin, 2021, 43(1):1-2. | |
[12] |
ZHANG L, HUANG L, WEIGER C, et al. Prevalence, correlates, and behavioral outcomes of alcohol gifting in China[J]. BMC Public Health, 2022, 22(1):1653.
doi: 10.1186/s12889-022-13946-8 pmid: 36045342 |
[13] | 王拥军, 李子孝, 谷鸿秋, 等. 中国卒中报告2019(中文版)(1)[J]. 中国卒中杂志, 2020, 15(10):1037-1043. |
WANG Y J, LI Z X, GU H Q, et al. China Stroke Statistics 2019 (1)[J]. Chin J Stroke, 2020, 15(10):1037-1043.
doi: 10.3969/j.issn.1673-5765.2020.10.001 |
|
[14] |
WANG Y, ZHAO L, GAO L, et al. Health policy and public health implications of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(7):446-461.
doi: 10.1016/S2213-8587(21)00118-2 URL |
[15] |
HOWARD V J, MCDONNELL M N. Physical activity in primary stroke prevention: just do it![J]. Stroke, 2015, 46(6):1735-1739.
doi: 10.1161/STROKEAHA.115.006317 pmid: 25882053 |
[16] |
CAO J, ESHAK E S, LIU K, et al. An age-period-cohort analysis of stroke mortality attributable to low physical activity in China and Japan: data from the GBD study 1990-2016[J]. Sci Rep, 2020, 10(1):6525.
doi: 10.1038/s41598-020-63307-x pmid: 32300134 |
[17] |
MURPHY R P, REDDIN C, ROSENGREN A, et al. Depressive symptoms and risk of acute stroke: INTERSTROKE case-control study[J]. Neurology, 2023, 100(17):e1787-e1798.
doi: 10.1212/WNL.0000000000207093 pmid: 36889922 |
[18] |
LU J, XU X, HUANG Y, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2021, 8(11):981-990.
doi: 10.1016/S2215-0366(21)00251-0 pmid: 34559991 |
[19] | 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56. |
Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, et al. 2018 Chinese guidelines for the management of hypertension Writing Group of 2018[J]. Chin J Cardiovasc Med, 2019, 24(1):24-56. | |
[20] | LI Y, TENG D, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369:m997. |
[21] |
YAGHI S, ELKIND M S. Lipids and cerebrovascular di-sease: research and practice[J]. Stroke, 2015, 46(11):3322-3328.
doi: 10.1161/STROKEAHA.115.011164 URL |
[22] |
SONG P K, MAN Q Q, LI H, et al. Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015[J]. Biomed Environ Sci, 2019, 32(8):559-570.
doi: 10.3967/bes2019.074 pmid: 31488232 |
[23] | OLADIRAN O, NWOSU I. Stroke risk stratification in atrial fibrillation: a review of common risk factors[J]. J Community Hosp Intern Med Perspect, 2019, 9(2):113-120. |
[24] |
DU X, GUO L, XIA S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7):535-541.
doi: 10.1136/heartjnl-2020-317915 URL |
[25] |
JACOB M A, EKKER M S, ALLACH Y, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults-a worldwide meta-analysis: the GOAL initiative[J]. Neurology, 2022, 98(6):e573-e588.
doi: 10.1212/WNL.0000000000013195 URL |
[26] |
LACKLAND D T, ROCCELLA E J, DEUTSCH A F, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(1):315-353.
doi: 10.1161/01.str.0000437068.30550.cf pmid: 24309587 |
[27] | YAO M, REN Y, JIA Y, et al. Projected burden of stroke in China through 2050[J]. Chin Med J (Engl), 2023, 136(13):1598-1605. |
[28] | LUO Y, SU B, ZHENG X. et al. Trends and challenges for population and health during population aging - China, 2015-2050[J]. China CDC Wkly, 2021, 3(28):593-598. |
[29] |
RU X, WANG W, SUN H, et al. Geographical difference, rural-urban transition and trend in stroke prevalence in China: findings from a national epidemiological survey of stroke in China[J]. Sci Rep, 2019, 9(1):17330.
doi: 10.1038/s41598-019-53848-1 |
[30] |
TU W J, ZHAO Z, YIN P, et al. Estimated burden of stroke in China in 2020[J]. JAMA Netw Open, 2023, 6(3):e231455.
doi: 10.1001/jamanetworkopen.2023.1455 URL |
[31] |
ORNELLO R, DEGAN D, TISEO C, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis[J]. Stroke, 2018, 49(4):814-819.
doi: 10.1161/STROKEAHA.117.020031 pmid: 29535272 |
[32] |
WU S, WU B, LIU M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405.
doi: S1474-4422(18)30500-3 pmid: 30878104 |
[33] | LIANG J, LUO C, KE S, et al. Stroke related knowledge, prevention practices and associated factors among stroke patients in Taizhou, China[J]. Prev Med Rep, 2023, 35:102340. |
[1] | 常宇宸, 李京波. 心肌梗死中铁死亡标志物研究进展[J]. 诊断学理论与实践, 2023, 22(02): 197-202. |
[2] | 王泽洲, 郑莹. 1990年至2020年间全球及我国肺癌的发病流行趋势及防控措施[J]. 诊断学理论与实践, 2023, 22(01): 1-7. |
[3] | 张超, 高雪. 继发进展型多发性硬化的临床诊断进展[J]. 诊断学理论与实践, 2022, 21(06): 669-676. |
[4] | 李佳曦, 汪锦江, 俞立萍, 袁英, 乔光磊, 马俐君. RAB25沉默抑制结直肠癌细胞铁死亡的作用研究[J]. 诊断学理论与实践, 2022, 21(06): 710-718. |
[5] | 崔岩, 葛海萍. 老年脑卒中后患者营养风险筛查研究[J]. 诊断学理论与实践, 2022, 21(06): 726-729. |
[6] | 张美玲, 朱潇邦, 宋爱玲, 周剑平, 李庆云. 小细胞肺癌患者采用PD-L1抑制剂治疗致垂体炎1例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(06): 741-745. |
[7] | 陈志敏, 刘波, 何浩岚, 何耀祖, 冯理智, 刘新华, 张坚生, 蔡卫平, 李凌华. 133例艾滋病合并马尔尼菲篮状菌病死亡病例分析[J]. 诊断学理论与实践, 2022, 21(04): 444-449. |
[8] | 鲍萍萍, 吴春晓, 顾凯, 庞怡, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 吴梦吟, 付晨, 施燕. 上海市2016年胃癌发病特征及2002年至2016年胃癌发病趋势分析[J]. 诊断学理论与实践, 2022, 21(04): 462-469. |
[9] | 宋洛卿, 戴廷军. 原发性抗磷脂综合征合并烟雾综合征一例并文献复习[J]. 诊断学理论与实践, 2022, 21(04): 497-503. |
[10] | 陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534. |
[11] | 魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7. |
[12] | 梁亚丽, 赵海港, 项广宇. 应激性高血糖比值预测急性缺血性脑卒中患者溶栓治疗后1年不良预后的价值[J]. 诊断学理论与实践, 2021, 20(06): 562-566. |
[13] | 刘安平, 凌枫, 史超, 孙璟. 上海社区老年脑卒中患者跌倒风险因素分析及风险识别模型的建立[J]. 诊断学理论与实践, 2021, 20(05): 475-479. |
[14] | 施仲伟. 回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021, 20(04): 349-355. |
[15] | 戎天艺, 花芸, 陈德艳, 何旻. 血清天冬酰胺内肽酶与急性大动脉粥样硬化型卒中间相关性的前瞻性研究[J]. 诊断学理论与实践, 2021, 20(02): 184-189. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||